Cargando…
Frequency of Hepatorenal Syndrome Among Patients With Cirrhosis and Outcome After Treatment
Introduction Hepatorenal syndrome is the third most common cause of admissions among patients with liver cirrhosis and has a high mortality rate. It is a progressive deterioration of renal function in a patient with acute or chronic liver failure. The only definite curative treatment of choice for h...
Autores principales: | Fida, Samina, Khurshid, Syed Murtaza S, Mansoor, Hala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515548/ https://www.ncbi.nlm.nih.gov/pubmed/32983712 http://dx.doi.org/10.7759/cureus.10016 |
Ejemplares similares
-
A Review of Hepatorenal Syndrome
por: Subedi, Abinash, et al.
Publicado: (2021) -
A Comprehensive Systematic Review of the Latest Management Strategies for Hepatorenal Syndrome: A Complicated Syndrome to Tackle
por: Roy, Pooja, et al.
Publicado: (2023) -
The Association of Helicobacter pylori With Portal Hypertensive Gastropathy in Patients With and Without Cirrhosis
por: Noor, ., et al.
Publicado: (2022) -
A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
por: Thangaraj, Santhosh Raja, et al.
Publicado: (2023) -
Frequency of Venous Thromboembolism in Patients with Liver Cirrhosis
por: Omer Sultan, Muhammad, et al.
Publicado: (2020)